This study has demonstrated that the positivity of neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule-1 (KIM-1) will be effective on breast cancer, especially in situ component-rich ones.
•This result showed that NGAL and KIM-1 may be effective during the early carcinogenesis of breast cancer.• Recently the new immune modulatory drug for TIM-1.• Considering the development of anti-KIM-1 therapies, the presence of KIM-1 expression may be a new treatment option in breast cancer.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.